Express Diagnostics today announced the launch of the first-ever onsite, lateral flow test for ethyl glucuronide (EtG), a unique biomarker of alcohol use. The new DrugCheck® Rapid EtG™ (Patent Pending) urine test delivers accurate, reliable results in as little as one minute, at a fraction of the cost of lab-based EtG tests.
Express Diagnostics Int’l recently launched a comprehensive system that combines Drug Abuse Recognition training with utilization of onsite drug screening devices. DrugCheck® DAR-OS™ integrates drug detection systems similar to processes currently used in identifying alcohol-related offenses.
Representatives from the company will be speaking next week at the 2014 conference of End Violence Against Women International (EVAWI), April 22-24 in Seattle, Wash. E
